Tartrate- and imidazole-derived diketones and diols
1135
112.90, 126.45, 127.20, 128.29, 129.15, 129.27, 129.45,
130.49, 133.33, 135.33, 138.27, 141.36, 186.50 ppm; IR
870, 781, 698 cm-1; ESI–MS: m/z = 595 (M ? 1)?, 1211
(2M ? 23)?.
ꢀ
(neat): m = 3,053, 2,985, 2,934, 1,684 (C=O), 1,446, 1,379,
[(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-diyl]bis-
[bis(1-methyl-4,5-diphenyl-1H-imidazol-2-yl)methanol]
(11, C71H62N8O4)
1,202, 1,112, 1,025, 989, 954, 902, 770, 694 cm-1; EI-MS
(70 eV): m/z = 234 (100), 218 (14), 165 (48); ESI–MS: m/
z = 623 (M ? 1)?, 645 (M ? 23)?, 1,267 (2M ? 23)?.
Off-white solid. Yield 262 mg (48%); m.p.: 197–198 °C;
Rf = 0.63 (SiO2; EtOAc/hexane 1:2); [a]2D0 = -85.6°
General procedure for the synthesis of diols 9–11
1
cm2 g-1 (c = 0.5, MeOH); H NMR (400 MHz, CDCl3):
d = 1.59 (s, 6H, 2 9 CH3), 2.73 (s, 6H, 2 9 NCH3), 3.93 (s,
6H, 2 9 NCH3), 5.86 (s, 2H, 2 9 CH), 7.05–7.53 (m, 40H,
Ph), 9.60 (br s, 2H, OH) ppm; 13C NMR (100 MHz, CDCl3):
d = 27.13, 31.84, 34.10, 74.59, 81.58, 106.69, 125.85,
126.25, 126.54, 126.66, 127.99, 128.14, 128.52, 128.59,
128.89, 128.94, 130.24, 130.46, 130.96, 131.10, 131.43,
131.83, 133.26, 134.03, 135.24, 135.76, 146.44, 149.28 ppm;
To imidazole 2–4 (2.0 mmol) dissolved in 20 cm3 THF,
1.28 cm3 of nBuLi (2.05 mmol, 1.6 M solution in hexane)
was added at 0 °C under argon. The yellow or orange
reaction mixture was stirred for 15 min, whereupon dike-
tone 6–8 (0.5 mmol) dissolved in 15 cm3 THF was added.
The reaction mixture was stirred for 1.5 h at 0 °C and
poured into a vigorously stirred biphasic system of 50 cm3
aqueous KH2PO4 (10%) and 50 cm3 CH2Cl2. The organic
phase was separated, the aqueous layer was extracted with
2 9 50 cm3 CH2Cl2, the combined organic layers were
dried (Na2SO4), and the solvents were evaporated at
reduced pressure. The resulting crude product was purified
on column chromatography using the indicated solvent
system.
ꢀ
IR (neat): m = 2,887 (OH), 1,600, 1,504, 1,441, 1,370, 1,230,
1,133, 1,053, 1,024, 908, 771, 693 cm-1
m/z = 1,113 (M ? 23)?.
; ESI–MS:
Stability constant b determination
The stability constants of the complexes prepared from
ligands 6–11 and Cu2? ions were determined by spectro-
photometric titration at 25 °C. A 1-cm-wide quartz cuvette
was filled with 3 cm3 of ligand solution in methanol
(c = 2 9 10-5 mol/dm3) and the absorption spectrum was
measured in the range of wavelengths k from 280 to
350 nm. A 745 mm3 quantity of solution of copper(II)
acetate in methanol (c = 2 9 10-3 mol/dm3, the accurate
concentration was determined by ICP) was added gradually
in 2–50-mm3 portions. The additions were optimized with
respect to the molar ratio of ligand:metal (15:1 at the
beginning, 1:25 at the end, 45 additions overall). The
absorption spectra were recorded upon each Cu2? addition.
The absorption spectrum of 745 mm3 of the aforemen-
tioned copper(II)acetate solution in 3 cm3 of methanol was
measured at the end. The stability constants b and their
molar absorption coefficients e (k) were calculated from the
matrix of measured absorbancies (row—concentrations,
columns—wavelengths) employing the program OPchem
[31]. The same program was used for the determination of
the number of particles in the solution and for the indica-
tion of the complexes with the given ratio of metal:ligand.
[(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-diyl]bis[bis(1-
methyl-1H-imidazol-2-yl)methanol] (9, C23H30N8O4)
Off-white solid. Yield 161 mg (67%); m.p.: 204–205 °C;
Rf = 0.25
(SiO2;
EtOAc/MeOH
5:1);
[a]2D0
=
-206.8° cm2 g-1 (c = 0.5, MeOH); H NMR (400 MHz,
CDCl3): d = 1.32 (s, 6H, 2 9 CH3), 3.24 (s, 6H,
2 9 NCH3), 3.98 (s, 6H, 2 9 NCH3), 5.33 (s, 2H,
2 9 CH), 6.47 (s, 4H, 4 9 CHim), 6.77 (s, 2H, 2 9 CHim),
6.82 (s, 2H, 2 9 CHim), 9.26 (br s, 2H, OH) ppm; 13C
NMR (100 MHz, CDCl3): d = 26.79, 33.93, 35.62, 73.74,
81.21, 106.27, 122.35, 122.54, 123.69, 126.92, 146.78,
1
ꢀ
149.03 ppm; IR (neat): m = 2,981 (OH), 1,461, 1,388,
1,280, 1,239, 1,118, 1,070, 985, 896, 728, 717, 685 cm-1
ESI–MS: m/z = 505 (M ? 23)?, 987 (2M ? 23)?.
;
[(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-diyl]bis-
[bis(1,4,5-trimethyl-1H-imidazol-2-yl)methanol]
(10, C31H46N8O4)
Off-white solid. Yield 196 mg (66%); m.p.: 139–140 °C;
Rf = 0.30 (SiO2; EtOAc/MeOH 5:1); [a]2D0 = -
143.6° cm2 g-1 (c = 0.5, MeOH); 1H NMR (400 MHz,
CDCl3): d = 1.35 (s, 6H, 2 9 CH3), 1.81 (s, 6H,
2 9 CimCH3), 1.89 (s, 6H, 2 9 CimCH3), 2.04 (s, 6H,
2 9 CimCH3), 2.12 (s, 6H, 2 9 CimCH3), 3.10 (s, 6H,
2 9 NCH3), 3.84 (s, 6H, 2 9 NCH3), 5.26 (s, 2H,
2 9 CH), 9.53 (br s, 2H, OH) ppm; 13C NMR
(100 MHz, CDCl3): d = 8.62, 9.35, 11.92, 13.03, 26.97,
31.20, 33.08, 73.77, 81.58, 105.99, 123.15, 123.77, 128.20,
131.13, 144.98, 147.24 ppm; IR (neat): ꢀm = 2,918 (OH),
1,721, 1,440, 1,396, 1,369, 1,222, 1,128, 1,069, 1,004, 911,
Acknowledgments This research was supported by the Czech
Science Foundation (203/08/0208) and the Ministry of Education,
Youth, and Sport of the Czech Republic (MSM 002167501).
References
´
´
1. Gawronski J, Gawronska K (1999) Tartaric and malic acids in
synthesis. Wiley, New York
123